Inder founded Kinsa in 2012 with a mission to curb the spread of infectious illness through the use of technology. Prior to Kinsa, he served as Executive Vice President of the Clinton Health Access Initiative (CHAI), where he brokered a series of agreements between 70 developing countries and 20 pharmaceutical companies to lower the price of AIDS, malaria and TB medicines which resulted in more than $1 billion in cost savings and enabled millions of children to access treatment.